Lexicon Pharmaceuticals Inc

Research Lexicon Pharmaceuticals Inc (LXRX) on Bullrun: market cap USD 1.17B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerLXRX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.17B
• Financial periodFY2025
• RevenueUSD 49.80M
• Revenue growth729.9%
• Net income-USD 50.34M
• Free cash flow-USD 67.85M
• Gross margin99.4%

Valuation Snapshot

latest market cap is USD 1.17B.

About Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes.

Frequently asked questions

What is Lexicon Pharmaceuticals Inc's market cap?

Lexicon Pharmaceuticals Inc's market capitalization is USD 1.17B.

What does Lexicon Pharmaceuticals Inc do?

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease.